WO2024116025A1 - Point of interest (poi) map for cardiac arrhythmia diagnosis - Google Patents
Point of interest (poi) map for cardiac arrhythmia diagnosis Download PDFInfo
- Publication number
- WO2024116025A1 WO2024116025A1 PCT/IB2023/061773 IB2023061773W WO2024116025A1 WO 2024116025 A1 WO2024116025 A1 WO 2024116025A1 IB 2023061773 W IB2023061773 W IB 2023061773W WO 2024116025 A1 WO2024116025 A1 WO 2024116025A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- poi
- graphically
- pois
- parameters
- map
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/339—Displays specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/283—Invasive
- A61B5/287—Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/361—Detecting fibrillation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/367—Electrophysiological study [EPS], e.g. electrical activation mapping or electro-anatomical mapping
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
Definitions
- the present di sclosure relates generally to cardiac electrophysiological (EP ) mapping, and particularly to cardiac EP maps .
- U . S . Patent Application Publication 2022 / 0211314 describes a method including receiving ( i ) a modeled surface of at least a portion of a heart and ( ii ) multiple EP values measured at multiple respective positions in the heart . Multiple regions are defined on the modeled surface and, for each region, a confidence level i s estimated for the EP values whose positions fall in the region .
- the modeled surface is presented to a user, including ( i ) the EP values overlaid on the modeled surface, and ( ii ) the confidence level graphically visualized in each region of the modeled surface .
- U . S . Patent 11 , 160 , 485 describes a method including storing an anatomical map of at least a portion of a surface of a heart .
- Respective electrogram (EGM) signal amplitudes measured at respective positions on the surface of the heart are stored .
- EGM signal amplitudes Based on the EGM signal amplitudes , defined are : one or more first regions of the surface in which the EGM signal amplitudes are fractionated, and one or more second regions of the surface in which the EGM signal amplitudes are non-f ractionated .
- a first surface representation is generated for the fractionated EGM signal amplitudes in the first regions .
- Propagation times are extracted from the non-f ractionated EGM signal amplitudes in the second regions , and a second surface representation of the propagation times i s derived .
- the first and second surface representations of the respective first and second regions of the surface are simultaneously presented, overlaid on the anatomical map .
- Julien S. et al describe in a paper titled, "Atrial Fibrillation (AF) Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation," JACC . Vol. 69, No. 3, (2017) , how to identify with EP mapping clustering of intracardiac electrograms exhibiting spatiotemporal dispersion is indicative of AF drivers.
- Fig. 1 is a schematic, pictorial illustration of a catheterbased electrophysiology (EP) mapping and ablation system, in accordance with an example of the present disclosure
- Fig. 2 is a schematic illustration of a points of interest (POI) map, in accordance with an example of the present disclosure
- Fig. 3 is a schematic illustration of a POI map, in accordance with another example of the present disclosure.
- Fig. 4 is a flow chart that schematically illustrates a method for generating, editing and presenting a POI map, in accordance with an example of the present disclosure.
- Probe-based cardiac diagnostic and therapeutic systems may measure a large number of intra-cardiac electrophysiological (EP) signals, such as electrograms (EGM) , during an invasive procedure.
- EP intra-cardiac electrophysiological
- EMM electrograms
- the analysis of such a vast amount of EP information is facilitated by generating and presenting to a user (e.g., a physician or a clinical application specialist) one or more EP maps.
- a user e.g., a physician or a clinical application specialist
- Each such EP map can display typical EP parameters for the procedure.
- Examples of EP parameters that may be presented include the arrhythmiaindicative EP parameters selected from a list comprising cycle length, regional ripple percentage, local activation time (LAT) , bipolar potential, activation wave velocity, and complex fractionated atrial electrograms (CFAE) .
- LAT local activation time
- CFAE complex fractionated atrial electrograms
- a physician performing diagnosis and/or planning a treatment for cardiac arrhythmia typically flips between the different EP maps to examine a variety of cardiac tissue properties.
- diagnosis and planning e.g., selection of an ablation location to eliminate an arrhythmia
- the physician flipping between the different EP maps may get lost in details and confusing indications, and thus may not be able to prioritize tissue locations for treatment.
- Examples of the present disclosure that are described herein provide algorithms and visualizations for high-level and fully automated acquisition and/or selection of EP data points for display .
- a user or a processor sets acquisition criteria, to acquire only data points that meet these criteria for use in analysis.
- Such criteria include stability of acquisition for a minimal predefined duration of time (e.g., 2.5 Seconds) for a minimum predefined number of electrodes (e.g., a group of electrodes that covers a minimal contiguous tissue area at once) of the multi-electrode catheter.
- the disclosed techniques may use a GUI to select several types of EP parameters and respective criteria applied to the acquired data points.
- a processor analyzes and displays points of interest (POI) maps, as will be described below.
- POI points of interest
- a processor displays an anatomical map overlayed with graphically encoded (e.g., flagged) POIs.
- the processor receives multiple EP data points comprising respective locations on the cardiac anatomical surface, and respective values of arrhythmia-indicative EP parameters at the locations .
- the processor applies respective criteria to the values of the EP data points . For each EP data point whose value meets a respective criterion, the proces sor graphically encodes the EP data point to generate a point of interest (POI ) .
- POI point of interest
- the processor superimposes POI s of at least two types of arrhythmia-indicative EP parameters on the anatomical surface as to generate a POI map reflecting surface locations likely of being arrhythmogenic, and visualize the POI map to a user, on the display .
- the processor divides the cardiac anatomical surface into unit areas of predefine si ze and shape, and per each unit area, or given portion of the unit areas , determines a count of dif ferently encoded POI s therein, and graphically indicate the count at the unit area .
- a graphical indication (e . g . , a flag) may be shaped and/or color-coded to indicate the EP parameter that it represent s .
- the disclosed POI map does not indicate the value of each of the EP parameters , only the location in the anatomical map at which the EP parameter value meets a criterion .
- ti ssue that shows arrhythmogenic behavior may be flagged by multiple flags , or by a special flag indicative of multiple flags .
- the flag may be a pin or a mosaic of colors on the anatomical map .
- the graphical indication may be embedded in the surface itself , such as in wavefronts that are displayed using a continuous color code, as done, for example , with coherent EP maps , and with spatiotemporal di spersion maps .
- the anatomical map may be a modeled map ( fast anatomical map, FAM) or a 3D image of a portion of the heart .
- the processor may divide the anatomical maps into unit areas of predefined size and shape , and, in each unit area, generate from dif ferent flags of different EP parameters a combined flag indicative of the multiple flags therein . For example, if the flags are stripes of dif ferent colors , the proces sor may generate therein a complex stripe pattern representative of the dif ferent colors .
- the proces sor di splays an EP map, such as a spatial-temporal di spersion map ( sequential activation of consecutive bipolar of multielectrode catheter spanning more than 85% ( 70-90% ) of has max derivative above defined threshold of the atrial fibrillation cycle length) over which the proces sor adds protruding color-coded pins to indicate additional parameters of interest for the arrhythmia .
- the proces sor may generate this way a POI map of atrial fibrillation (AFib) that will assist the physician in determining where to ablate tis sue .
- a user may alter the height and/or width of the pins depending on the criterion they are selected to represent .
- Red pins for locations with regularity in cycle-length defined, for example , as point s within a range of [minimum cyclelength, minimum cycle-length + 10 ms ]
- a POI map is provided to a physician with a color scale that classifies areas according to the number of parameters that indicate an arrhythmia therein .
- a physician i s able to choose from a li st of parameters to be used to build the map .
- the physician may choose five parameters .
- a scale on the map shows the number of these chosen parameters , e . g . , ranging from 0 to 5 , that af fect a given region of the map . The physician may consider that regions showing a 5 are candidates for ablation .
- the physician may choose di fferent EP parameters from the list to be counted in the EP parameter scale .
- the physician may assign weights to the parameters .
- a proces sor is used in training a machine-learning model with a sufficient number of POI maps to construct an expert application that can generates one or more optimized POI maps .
- Fig . 1 i s a schematic, pictorial illustration of a catheterbased electrophysiology (EP ) mapping and ablation system 10 , in accordance with an example of the present disclosure .
- System 10 may include multiple catheters , which are percutaneously inserted by physician 24 through the patient ' s vascular system into a chamber or vascular structure of a heart 12 .
- a delivery sheath catheter is inserted into the left or right atrium near a desired location in heart 12 .
- a plurality of catheters can be inserted into the delivery sheath catheter so as to arrive at the desired location .
- the plurality of catheters may include catheters dedicated for sensing intracardiac electrogram (IEGM) signals , catheters dedicated for ablation and/or catheters dedicated for both sensing and ablation .
- An example EP mapping catheter 14 that i s configured for sensing IEGM i s illustrated herein .
- Physician 24 brings a di stal tip 28 (al so called hereinafter "distal end as sembly 28" ) of catheter 14 into contact with the heart wall for sensing a target site in heart 12 .
- physician 24 similarly brings a distal end of an ablation catheter to a target site for ablation .
- Catheter 14 is an exemplary catheter that includes one, and preferably multiple , electrodes 26 optionally distributed over a plurality of splines 22 at di stal tip 28 and configured to sense IEGM signals .
- Catheter 14 may additionally include a position sensor 29 embedded in or near distal tip 28 for tracking position and orientation of distal tip 28.
- position sensor 29 is a magnetic-based position sensor including three magnetic coils for sensing three-dimensional (3D) position and orientation.
- Magnetic-based position sensor 29 may be operated together with a location pad 25 that includes a plurality of magnetic coils 32 configured to generate magnetic fields in a predefined working volume. Real-time position of distal tip 28 of catheter 14 may be tracked based on magnetic fields generated with location pad 25 and sensed by magnetic-based position sensor 29. Details of the magnetic based position sensing technology are described in U.S. Patent Nos. 5,5391,199; 5,443,489; 5,558,091; 6,172,499; 6,239,724; 6,332,089; 6,484,118; 6,618, 612; 6,690, 963; 6,788, 967; 6,892, 091.
- System 10 includes one or more electrode patches 38 positioned for skin contact on patient 23 to establish a location reference for location pad 25 as well as impedance-based tracking of electrodes 26.
- impedance-based tracking electrical current is directed toward electrodes 26 and sensed at electrode skin patches 38 so that the location of each electrode can be triangulated via the electrode patches 38. Details of the impedance-based location tracking technology are described in US Patent Nos. 7,536,218; 7,756,576; 7,848,787; 7,869,865; and 8 , 456, 182.
- a recorder 11 displays electrograms 21 captured with body surface ECG electrodes 18 and intracardiac electrograms (IEGM) captured with electrodes 26 of catheter 14.
- Recorder 11 may include pacing capability for pacing the heart rhythm and/or may be electrically connected to a standalone pacer.
- System 10 may include an ablation energy generator 50 that is adapted to conduct ablative energy to one or more electrodes at a distal tip of a catheter configured for ablation.
- Energy produced by ablation energy generator 50 may include, but is not limited to, radiofrequency (RE) energy or pulsed-field ablation (PFA) energy, including monopolar or bipolar high-voltage DC pulses as may be used to effect irreversible electroporation (IRE) , or a combinations thereof.
- RE radiofrequency
- PFA pulsed-field ablation
- IRE irreversible electroporation
- Patient interface unit (PIU) 30 is an interface configured to establish electrical communication between catheters, electrophysiological equipment, power supply and a workstation 55 for controlling the operation of system 10.
- Electrophysiological equipment of system 10 may include, for example, multiple catheters, location pad 25, body surface ECG electrodes 18, electrode patches 38, ablation energy generator 50, and recorder 11.
- PIU 30 additionally includes processing capability for implementing real-time location computations of the catheters and for performing ECG calculations.
- Workstation 55 includes memory 57, processor unit 56 with memory or storage with appropriate operating software loaded therein, and user interface capability. Workstation 55 may provide multiple functions, optionally including (1) modeling the endocardial anatomy in three-dimensions (3D) and rendering the model or a POI map 20 for display on a display device 27, (2) displaying on display device 27 activation sequences (or other data) compiled from recorded electrograms 21 in representative visual indicia or imagery included in the rendered POI map 20, (3) displaying real-time location and orientation of multiple catheters within the heart chamber, and (4) displaying on display device 27 sites of interest such as places where ablation energy has been applied.
- One commercial product embodying elements of system 10 is available as the CARTOTM 3 System, available from Biosense Webster, Inc., 31A Technology Drive, Irvine, CA 92618.
- Fig. 2 is a schematic illustration of a POI map 200, in accordance with an example of the present disclosure.
- POI map 200 may be the POI map 20 shown displayed in Fig. 1.
- POI map 200 comprises an anatomical map 202, which, in the shown case, is of a left atrium.
- POI map 200 further comprises graphically encoded (e.g., flagged) EP data points.
- the data POIs are for given unit areas on the map superimposed by at least two EP parameters .
- the flags may be graphically shaped and/or color coded to indicate the parameter that they represent .
- the disclosed POI map does not indicate the value of each of the EP parameters , only the location in the anatomical map at which the EP parameter value crosses a threshold .
- the processor di splays protruding color-coded pins indicating additional parameters of interest for an arrhythmia such as atrial fibrillation (AFib) .
- AFib atrial fibrillation
- An example of color-coded scheme for the protruding pins includes :
- Red pins 204 for locations with regularity in cycle length defined, for example, as points within a range of [minimum cycle-length, minimum cycle-length + 10 ms ]
- Blue pins 206 for locations with regularity in STD cycle length defined, for example, as points with STD in a range of [minimum STD cycle-length, minimum STD cycle-length + 5 ms ]
- pins 212 include different colored rings to mark locations where indications of pins 204 , 206 , and 208 overlap each other .
- EP wavefront s may be color coded ( 214 ) on the map as well , as done , for example, with coherent EP maps .
- One or more areas on the EP map can be graphically encoded ( 215 ) , i f the analysis shows the area demonstrates spatiotemporal dispersion above a given slope .
- Such dispersion can be determined i f a sufficient number of electrodes cover an are under test for a sufficient time duration .
- FIG. 3 is a schematic illustration of a POI map 300, in accordance with another example of the present disclosure.
- POI map 300 may be the POI map 20 shown displayed in Fig. 1.
- POI map 300 comprises an anatomical map 302, which in the shown case is of a left atrium.
- POI map 300 is provided to a physician with a color scale that classifies areas according to the number of EP parameters indicative of an arrhythmia.
- a physician is able to choose from a list 304 of EP parameters to be used to build POI map 300.
- the physician may choose five EP parameters from a list of arrhythmia-indicative EP parameters such as the aforementioned cycle length, regional ripple percentage, local activation time (LAT) , bipolar potential, activation wave velocity, spatiotemporal dispersion slope, and complex fractionated atrial electrograms (CFAE) .
- a scale 306 on the map shows the number of these chosen EP parameters, e.g., ranging from 0 to 5, that affect a given region of the map. The physician may consider that regions 308 showing a 5 are candidates for ablation.
- the physician may choose different EP parameters from list 304 to be counted in the EP parameter scale 306. In addition, the physician may assign weights to the EP parameters.
- Fig. 4 is a flow chart that schematically illustrates a method for generating, editing and presenting a POI map, such as maps 200 and 300, in accordance with an example of the present disclosure.
- the algorithm carries out a process that begins with processor 28 receiving (e.g., uploading) a cardiac anatomical surface, such as anatomical maps 202 and 302, at an anatomical surface uploading step 402.
- the processor receives multiple EP data points on the anatomical surface that correspond (belong) each to one of a number of EP parameters, at EP data points receiving step 404.
- the processor applies to the EP data points respective (i.e., for each EP parameter) EP criteria. These may include EP values crossing thresholds or falling within ranges.
- the EP parameters may be taken from the aforementioned arrhythmia-indicative EP parameters of cycle length, regional ripple percentage, local activation time (LAT) , bipolar potential, activation wave velocity, spatiotemporal dispersion slope, and complex fractionated atrial electrograms (CFAE) .
- the processor graphically encodes each EP data that complies with a criterion, so as to generate a point of interest.
- the processor graphically indicates POIs in locations where at least two or more of the EP parameters meet respective predefined criteria (e.g., as seen in pins 212 of Fig. 2) and/or graphically indicate POIs according to a scale determining a count (e.g., up to 5 as seen in scale 306 of Fig. 3) of differently encoded POIs therein, and graphically indicate the count at the unit area.
- the processor has the POI map providing an indication of surface locations likely to be arrhythmogenic .
- the processor displays the POI map to a user, such as displaying map 20 on display device 27, at a POI map displaying step 412.
- a system (10) includes a display (27) and a processor (56) .
- the processor is configured to receive a cardiac anatomical surface (202, 302) , and to receive multiple electrophysiological (EP) data points comprising (i) respective locations on the cardiac anatomical surface and (ii) respective values of arrhythmiaindicative EP parameters at the locations, and apply respective criteria to the values of the EP data points.
- EP electrophysiological
- the processor For each EP data point whose value meets a respective criterion, the processor is configured to graphically encode (204, 206, 208, 210, 212) the EP data point to generate a point of interest (POI) , superimpose POIs of at least two types of arrhythmia-indicative EP parameters on the anatomical surface as to generate a POI map reflecting surface locations likely of being arrhythmogenic, and visualize the POI map to a user, on the display (27) .
- POI point of interest
- arrhythmia-indicative EP parameters are of types selected from a list comprising at least two of cycle-length, regional ripple percentage, local activation time (LAT) , bi-polar potential, activation wave velocity, spatiotemporal dispersion slope, and complex fractionated atrial electrograms (CFAE) .
- the system (10) according to any of examples 1 and 2, wherein the processor (56) is configured to visualize the POI map by dividing the cardiac anatomical surface (202, 302) into unit areas of predefined size and shape, and, per each unit area, determine a count of differently encoded (204, 206, 208, 210) POIs therein, and graphically indicate (306) the count at the unit area.
- the processor is configured to graphically indicate (204, 206, 208, 210) the count (306) by generating a new graphical indication reflecting the count of the differently graphically encoded POIs therein.
- the processor is configured to reflect the count (306) by combining the differently graphically encoded (204, 206 , 208 , 210 ) POI s into a single POI graphically encoded ( 212 ) to indicate each of the di fferently graphically encoded POI s therein .
- a method includes receiving a cardiac anatomical surface ( 202 , 302 ) .
- Multiple electrophysiological (EP ) data points are received, each comprising ( i ) respective locations on the cardiac anatomical surface and ( ii ) respective values of arrhythmiaindicative EP parameters at the locations .
- Respective criteria are applied to the values of the EP data points , for each EP data point whose value meets a respective criterion, the EP data point is graphically encoded ( 204 , 206 , 208 , 210 , 212 ) to generate a point of interest (POI ) .
- POI point of interest
- POI s of at least two types of arrhythmiaindicative EP parameters are superimposed on the anatomical surface as to generate a POI map reflecting surface locations likely of being arrhythmogenic .
- the POI map is vi suali zed to a user .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Physiology (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Description
Claims
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202380083117.8A CN120417839A (en) | 2022-12-01 | 2023-11-22 | Point-of-interest (POI) mapping for arrhythmia diagnosis |
| IL321187A IL321187A (en) | 2022-12-01 | 2023-11-22 | Point of interest (poi) map for cardiac arrhythmia diagnosis |
| EP23824966.8A EP4626317A1 (en) | 2022-12-01 | 2023-11-22 | Point of interest (poi) map for cardiac arrhythmia diagnosis |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263429272P | 2022-12-01 | 2022-12-01 | |
| US63/429,272 | 2022-12-01 | ||
| US18/500,441 | 2023-11-02 | ||
| US18/500,441 US20240180475A1 (en) | 2022-12-01 | 2023-11-02 | Point of interest (poi) map for cardiac arrhythmia diagnosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2024116025A1 true WO2024116025A1 (en) | 2024-06-06 |
Family
ID=89222681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2023/061773 Ceased WO2024116025A1 (en) | 2022-12-01 | 2023-11-22 | Point of interest (poi) map for cardiac arrhythmia diagnosis |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4626317A1 (en) |
| CN (1) | CN120417839A (en) |
| IL (1) | IL321187A (en) |
| WO (1) | WO2024116025A1 (en) |
Citations (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5391199A (en) | 1993-07-20 | 1995-02-21 | Biosense, Inc. | Apparatus and method for treating cardiac arrhythmias |
| US5558091A (en) | 1993-10-06 | 1996-09-24 | Biosense, Inc. | Magnetic determination of position and orientation |
| US6172499B1 (en) | 1999-10-29 | 2001-01-09 | Ascension Technology Corporation | Eddy current error-reduced AC magnetic position measurement system |
| JP2001061789A (en) * | 1999-07-22 | 2001-03-13 | Biosense Inc | Status display method by mapping |
| US6239724B1 (en) | 1997-12-30 | 2001-05-29 | Remon Medical Technologies, Ltd. | System and method for telemetrically providing intrabody spatial position |
| US6332089B1 (en) | 1996-02-15 | 2001-12-18 | Biosense, Inc. | Medical procedures and apparatus using intrabody probes |
| US6484118B1 (en) | 2000-07-20 | 2002-11-19 | Biosense, Inc. | Electromagnetic position single axis system |
| US6618612B1 (en) | 1996-02-15 | 2003-09-09 | Biosense, Inc. | Independently positionable transducers for location system |
| US6690963B2 (en) | 1995-01-24 | 2004-02-10 | Biosense, Inc. | System for determining the location and orientation of an invasive medical instrument |
| US6892091B1 (en) | 2000-02-18 | 2005-05-10 | Biosense, Inc. | Catheter, method and apparatus for generating an electrical map of a chamber of the heart |
| US7536218B2 (en) | 2005-07-15 | 2009-05-19 | Biosense Webster, Inc. | Hybrid magnetic-based and impedance-based position sensing |
| US20090192393A1 (en) * | 2007-11-29 | 2009-07-30 | Gal Hayam | Determining locations of ganglia and plexi in the heart using complex fractionated atrial electrogram |
| US7756576B2 (en) | 2005-08-26 | 2010-07-13 | Biosense Webster, Inc. | Position sensing and detection of skin impedance |
| US7848787B2 (en) | 2005-07-08 | 2010-12-07 | Biosense Webster, Inc. | Relative impedance measurement |
| US7869865B2 (en) | 2005-01-07 | 2011-01-11 | Biosense Webster, Inc. | Current-based position sensing |
| US8456182B2 (en) | 2008-09-30 | 2013-06-04 | Biosense Webster, Inc. | Current localization tracker |
| EP3750478A1 (en) * | 2019-06-11 | 2020-12-16 | Biosense Webster (Israel) Ltd | Visually differentiating primary and secondary activations on electrophysiological maps |
| US11160485B2 (en) | 2020-04-01 | 2021-11-02 | Biosense Webster (Israel) Ltd. | Propagation map of a heart chamber with areas demonstrating fractionated electrograms |
| US20220211314A1 (en) | 2021-01-07 | 2022-07-07 | Biosense Webster (Israel) Ltd. | Incorporating a confidence level into an electrophysiological (ep) map |
| EP4062833A1 (en) * | 2021-03-22 | 2022-09-28 | Biosense Webster (Israel) Ltd | Visualizing multiple parameters overlaid on an anatomical map |
-
2023
- 2023-11-22 WO PCT/IB2023/061773 patent/WO2024116025A1/en not_active Ceased
- 2023-11-22 IL IL321187A patent/IL321187A/en unknown
- 2023-11-22 CN CN202380083117.8A patent/CN120417839A/en active Pending
- 2023-11-22 EP EP23824966.8A patent/EP4626317A1/en active Pending
Patent Citations (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5443489A (en) | 1993-07-20 | 1995-08-22 | Biosense, Inc. | Apparatus and method for ablation |
| US5391199A (en) | 1993-07-20 | 1995-02-21 | Biosense, Inc. | Apparatus and method for treating cardiac arrhythmias |
| US5558091A (en) | 1993-10-06 | 1996-09-24 | Biosense, Inc. | Magnetic determination of position and orientation |
| US6690963B2 (en) | 1995-01-24 | 2004-02-10 | Biosense, Inc. | System for determining the location and orientation of an invasive medical instrument |
| US6618612B1 (en) | 1996-02-15 | 2003-09-09 | Biosense, Inc. | Independently positionable transducers for location system |
| US6332089B1 (en) | 1996-02-15 | 2001-12-18 | Biosense, Inc. | Medical procedures and apparatus using intrabody probes |
| US6788967B2 (en) | 1997-05-14 | 2004-09-07 | Biosense, Inc. | Medical diagnosis, treatment and imaging systems |
| US6239724B1 (en) | 1997-12-30 | 2001-05-29 | Remon Medical Technologies, Ltd. | System and method for telemetrically providing intrabody spatial position |
| JP2001061789A (en) * | 1999-07-22 | 2001-03-13 | Biosense Inc | Status display method by mapping |
| US6172499B1 (en) | 1999-10-29 | 2001-01-09 | Ascension Technology Corporation | Eddy current error-reduced AC magnetic position measurement system |
| US6892091B1 (en) | 2000-02-18 | 2005-05-10 | Biosense, Inc. | Catheter, method and apparatus for generating an electrical map of a chamber of the heart |
| US6484118B1 (en) | 2000-07-20 | 2002-11-19 | Biosense, Inc. | Electromagnetic position single axis system |
| US7869865B2 (en) | 2005-01-07 | 2011-01-11 | Biosense Webster, Inc. | Current-based position sensing |
| US7848787B2 (en) | 2005-07-08 | 2010-12-07 | Biosense Webster, Inc. | Relative impedance measurement |
| US7536218B2 (en) | 2005-07-15 | 2009-05-19 | Biosense Webster, Inc. | Hybrid magnetic-based and impedance-based position sensing |
| US7756576B2 (en) | 2005-08-26 | 2010-07-13 | Biosense Webster, Inc. | Position sensing and detection of skin impedance |
| US20090192393A1 (en) * | 2007-11-29 | 2009-07-30 | Gal Hayam | Determining locations of ganglia and plexi in the heart using complex fractionated atrial electrogram |
| US8456182B2 (en) | 2008-09-30 | 2013-06-04 | Biosense Webster, Inc. | Current localization tracker |
| EP3750478A1 (en) * | 2019-06-11 | 2020-12-16 | Biosense Webster (Israel) Ltd | Visually differentiating primary and secondary activations on electrophysiological maps |
| US11160485B2 (en) | 2020-04-01 | 2021-11-02 | Biosense Webster (Israel) Ltd. | Propagation map of a heart chamber with areas demonstrating fractionated electrograms |
| US20220211314A1 (en) | 2021-01-07 | 2022-07-07 | Biosense Webster (Israel) Ltd. | Incorporating a confidence level into an electrophysiological (ep) map |
| EP4062833A1 (en) * | 2021-03-22 | 2022-09-28 | Biosense Webster (Israel) Ltd | Visualizing multiple parameters overlaid on an anatomical map |
Non-Patent Citations (1)
| Title |
|---|
| JULIEN S. ET AL.: "Atrial Fibrillation (AF) Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation", JACC, vol. 69, no. 3, 2017 |
Also Published As
| Publication number | Publication date |
|---|---|
| IL321187A (en) | 2025-07-01 |
| EP4626317A1 (en) | 2025-10-08 |
| CN120417839A (en) | 2025-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2689722B1 (en) | An apparatus for mapping cardiac electrical activity | |
| EP3888553B1 (en) | Propagation map of a heart chamber with areas demonstrating fractionated electrograms | |
| US20240180475A1 (en) | Point of interest (poi) map for cardiac arrhythmia diagnosis | |
| EP4626317A1 (en) | Point of interest (poi) map for cardiac arrhythmia diagnosis | |
| WO2024110813A1 (en) | A three-dimensional display of a multi-electrode catheter and signals acquired over time | |
| JP2025541748A (en) | Point of interest (POI) map for cardiac arrhythmia diagnosis | |
| EP3614913A1 (en) | Connectivity analysis for arrhythmia drivers | |
| EP4570168A1 (en) | Gui to visually connect features identified in electroanatomical (ea) map to ecg signals | |
| EP4385414A1 (en) | Identifying focal sources of arrhythmia with multi electrode catheter | |
| US20250344983A1 (en) | Cardiac map advanced ripple mode with gui | |
| US20240285216A1 (en) | Local ecg annotation visualization | |
| EP4599768A1 (en) | Local ecg annotation visualization | |
| US20240315630A1 (en) | Visualizing local quality on an electrophysiological map | |
| EP4659694A1 (en) | Ablation tags indicator | |
| EP4494561A1 (en) | Estimation and visualization of electroanatomical (ea) analysis quality of an ea map | |
| JP2025184854A (en) | Ablation Tag Indicator | |
| JP2025173495A (en) | Ablation location prediction across anatomical maps | |
| JP2025172043A (en) | GUI-based cardiac map modulation | |
| WO2024110814A1 (en) | Focal arrhythmia source finder using directed graphs | |
| IL316930A (en) | Impedance-based tracking of catheter position relative to the cavity wall |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23824966 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 321187 Country of ref document: IL |
|
| ENP | Entry into the national phase |
Ref document number: 2025531752 Country of ref document: JP Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2025531752 Country of ref document: JP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202380083117.8 Country of ref document: CN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2023824966 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2023824966 Country of ref document: EP Effective date: 20250701 |
|
| WWP | Wipo information: published in national office |
Ref document number: 202380083117.8 Country of ref document: CN |
|
| WWP | Wipo information: published in national office |
Ref document number: 2023824966 Country of ref document: EP |